‘Do chemicals penetrate human skin?’ – Take-aways from the 4th EXIMIOUS Symposium​

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

'Do chemicals penetrate human skin?' – Take-aways from the 4th EXIMIOUS Symposium​

2 February 2023

More than 80 participants joined the fourth EXIMIOUS Symposium “Do chemicals penetrate human skin? How skin absorption of chemicals contributes to human exposure” held online last Thursday, 26 January 2023. Did you miss it? Worry not, you can watch the full recording on the EXIMIOUS YouTube channel.

The three guest speakers, Dr. Jos Bessems (VITO, Belgium), Dr. Anneli Julander (IVL Swedish Environmental Research Institute, Sweden), and Dr. Jeroen Vanoirbeek (Katholieke Universiteit Leuven, Belgium), each zoomed in on a different aspect of skin exposure to chemicals through their latest research. Altogether, they showed a broad picture of the topic that was accessible to the non-expert audience while also providing researchers in the field with new insights. 

In the first talk, Dr. Jos Bessems explained why the internal dose should be considered the key factor in creating toxicity. He showed that some chemicals can penetrate the human skin and be absorbed by it. The exact nature of this process depends on the route of penetration and other factors such as the skin’s hydration level but also age and gender. Dr. Anneli Julander focused on three case studies to explore the dynamics of skin penetration and absorption of metals as well as the so-called ‘reservoir effect’ observed for certain metals that through our skin may accumulate in the body over time. These case studies took us through the penetration of Nickel across damaged skin barriers (common for those who present atopic dermatitis), the role of skin as a previously neglected exposure route for cobalt and its importance especially in view of cobalt originating from nanoparticles (common in several modern industries and especially associated to 3D printing), and the potentially important reservoir effect for lead introduced through a study of lead exposure for workers in a brass foundry. Adding to the diversity of case studies, Dr. Jeroen Vanoirbeek introduced the case of firefighters and their exposure on the workplace to a complex mixture of chemicals, including polycyclic aromatic hydrocarbons (PAHs). PAHs are rated as carcinogenic to humans and, according to previous studies, skin cancer appears to be the most prevalent type of cancer among firefighters. However, while respiratory (inhalation exposure) protection measures for firefighters are well-established, skin (dermal exposure) protection and risk assessment tools are much less so. This is where Dr. Vanoirbeek’s study comes into play, as he presented an assessment of different compounds that could be best suited as indicators of PAH exposure and internal dose, to determine dermal exposure. As the results of this study are currently preliminary and of confidential nature, they are not shared in the recording of the event at this point.

While there is still much to be understood about skin exposure dynamics, this symposium highlighted the diversity of chemicals that can penetrate the skin, the role they might play in the body and immune system and the variety of situations in which skin exposure to chemicals can take place. We are grateful to the invited guest speakers for sharing their latest research and taking us through this insightful discovery journey. 

We’re looking forward to more exposome research highlights and insights during the Spring/Summer 2023 edition of the EXIMIOUS Symposium, so stay tuned. If you’d like to be notified about the next EXIMIOUS Symposium you can also subscribe here and we’ll send you an invitation in due time.

Registration is open for the 4th EXIMIOUS Symposium

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Registration is open for the 4th EXIMIOUS Symposium

6 December 2022

The fourth EXIMIOUS Symposium, titled “Do chemicals penetrate human skin? How skin absorption of chemicals contributes to human exposure”, will take place on 26 January 2023. Register now and join us online at 16:00 – 18:00 (CET) to learn more about skin exposure to chemicals.

What happens when the human skin comes into contact with particular chemicals? To what extent do they get absorbed into the body, and what are the health effects?

Our invited guest speakers will present their latest research on internal exposure and toxicity, skin exposure to metals, and the exposure of firefighters’ instructors. A dedicated time for Q&A will follow each of the presentations. Like our previous symposia, this fourth EXIMIOUS Symposium is open to all audiences.

Programme EXIMIOUS Symposium
Do chemicals penetrate human skin? How skin absorption of chemicals contributes to human exposure
Time Title Speaker

16:00 – 16:15

Welcome and introduction from the EXIMIOUS coordinator

Prof. Peter Hoet
Katholieke Universiteit Leuven, Belgium

16:15 – 16:50

Why ADME and ToxicoKinetics are pivotal to know: internal exposure as ‘missing link’ between exposure and toxicity

Dr. Jos Bessems
VITO, Belgium

16:50 – 17:25

Systemic dose of metals – the role of skin penetration, reservoir and absorption

Dr. Anneli Julander
IVL Swedish Environmental Research Institute, Sweden

17:25 – 18:00

External and internal exposure of firefighters’ instructors to polycyclic aromatic hydrocarbons

Dr. Jeroen Vanoirbeek
Katholieke Universiteit Leuven, Belgium

Speakers

Dr. Jos Bessems has been active in supporting chemicals management in the EU since 1996. He contributed to OECD Test Guideline development, the REACH Implementation Project, as well as the ECHA REACH Guidance. At VITO, Jos is working on tools for human biomonitoring as well as on how to increase its regulatory acceptance and use under the flag ‘policy support environment and health’  for Flemish, Belgian as well as European authorities. He also supports the European Environment Agency (EEA) and the European Commission’s Directorate General Environment (DG ENV) in early warning systems, classification and labelling and ‘substances of very high concern’. Jos is co-founder and board member of ISES Europe, contributed to its European Strategy for Exposure Science and is co-chairing its human biomonitoring working group.

Dr. Anneli Julander holds a PhD in Environmental Science from Örebro University in 2004. She continued her research career at Karolinska Institutet, Sweden, where she received her appointment to Docent in Occupational and Environmental Medicine in 2014. Anneli is currently working at IVL Swedish Environmental Research Institute as a senior researcher and work environment expert. Her research area is to study how toxic and allergenic chemicals interact with human skin and causes local and systemic effects.

Dr. Jeroen Vanoirbeek graduated in 1999 as master in Biology. In 2004 he obtained his PhD at the KU Leuven. His research focused on chemical-induced asthma and specifically the mechanisms of the skin-lung interactions in relation to chemical sensitization. Currently, he leads the Laboratory for Occupational and Environmental Hygiene in the Centre for Environment and Health at the KU Leuven. His main research topics are respiratory and skin exposure assessment, in combination with biological monitoring; clinical-epidemiological research on occupational health; and mechanisms of skin-lung inaction of chemicals in experimental models. In his current appointment, he is responsible for teaching occupational hygiene and prevention management.

EHEN’s November 2022 Newsletter – focus on the health impact of exposome research​

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

EHEN's November 2022 Newsletter - focus on the health impact of exposome research

10 November 2022

The European Human Exposome Network (EHEN) just released its third newsletter and you don’t want to miss it. Alongside providing updates from the network’s working groups and the 9 exposome projects (including EXIMIOUS) that are part of it, the newsletter introduces the health impact of exposome reaserach, exploring the breadth and diversity of the diseases being studied by the EHEN projects.

How can the research outputs of EHEN have a concrete impact on health and what is th erole of policymakers? Which four health areas are of focus across the nine EHEN projects? What are autoimmune diseases, and did you know they are also of interest in exposome studies? You can find the answer to these and many other questions by reading the full Newsletter.

The newsletter also announces the launch of the EHEN Toolbox, where the tools developed by the projects are all collected in an online go-to resource for all stakeholders interested in exposome research. Moreover, in the newsletter you’ll also find the latest publications from all nine projects, with a featured publication from the LongITools project focused on cardiovascular health.

Enjoy the read!

Partner in the spotlight: NIPH

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Partner in the spotlight: NIPH

September 5, 2022

Our partner in the spotlight series continues, and we’re glad to present the Norwegian Institute of Public Health (NIPH). The NIPH is a research institute organized under the Ministry of Health in Norway. Its goal is to produce and communicate knowledge on health-related topics to the Norwegian government, to promote a longer and healthier life. Topics covered include infectious diseases, environmental health, non-communicable diseases and mental health. To perform these tasks, the institute has an infrastructure of laboratories, registries and biobanks in place. The main outputs are systematic reviews and advisory reports to support the government in the development of policies on health and care services. The knowledge is based on an extensive research portfolio that is mainly funded by external grants from the Norwegian Research Council, the European Union and others.

The Department of Environmental Health at NIPH provides research data on the effects of environmental factors like chemicals, air pollution, radiation and noise on human health. Exposure to chemicals is studied with a state-of-the-art biological monitoring laboratory. The research portfolio supports science-based advice to the Norwegian Food Safety Authority and the Norwegian Environment Agency, and their European counterparts EFSA and ECHA. Chemical hazard and risk assessments are important deliveries of the department as well as research activities related to immunotoxicology, epigenetics, inhalation toxicology and neurotoxicology. The department is also a partner in several EU projects, including HBM4EU, ATHLETE, POLYRISK, ULTHRAS, ONTOX and the Partnership for the Assessment of Risk from Chemicals (PARC).

Our department aims to drive the field of immunotoxicology forward by identifying immune effect biomarkers for use in epidemiological exposure studies as well as develop in vitro screening assays. To achieve this, our work focuses on high-dimensional immune profiling and systems immunology. Mass cytometry, also called cytometry by time-of-flight (CyTOF), has emerged as a powerful tool for high-dimensional analysis of the immune system’s cellular composition and function at the single-cell level. The CyTOF platform at NIPH has expertise in CyTOF applications within the fields of toxicology, immune-related diseases, systems immunology, bioinformatics, infections and vaccinology.

In EXIMIOUS, NIPH is represented by an experienced team of researchers including Unni C. Nygaard, Berit Granum, Hubert Driven, Nur Duale, Hege Hijertholm, Birgille Linderman, Anette Kocbach Bolling, and Evangel Kummari. They make use of CyTOF to identify immune-cell signatures that are able to discriminate between autoimmune disease states or exposure patterns in cohort studies, and to study changes in immune-cell function following exposure of selected components of the exposome in vitro. The CyTOF analysis enables simultaneous detection of 40-50 markers and will include markers for classification of immune-cell subtypes and their activation status as well as functional markers such as intracellular cytokines. Unsupervised algorithms and statistical analyses will be used to identify immune-cell profiles associated with exposures and specific health outcomes. NIPH will also be responsible for delivering epigenetic data on DNA methylation and microRNAs.

The NIPH team of researchers contributinmg to the EXIMIOUS project.

Immune differentiation linked to age and exposure: outputs from the 3rd EXIMIOUS Symposium​

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Immune differentiation linked to age and exposure: outputs from the 3rd EXIMIOUS Symposium

5 July 2022

The third EXIMIOUS Symposium “Immune differentiation linked to age and exposure” was held online on 23 June 2022. Don’t worry if you missed it, the full recording of the event is available on the EXIMIOUS YouTube channel.

Three invited guest speakers, Prof. Niels Hellings (Hasselt University, Belgium), Dr. Juan Aguilera (Stanford University, USA) and Dr. Tobias Stöger (Helmholtz Zentrum München, Germany), presented their latest research on the effects of diverse aspects of aging and exposure on immune differentiation. 

To kick-off the event, Prof. Peter Hoet  and Dr. Manosij Ghosh (KU Leuven, EXIMIOUS coordinating team) introduced the EXIMIOUS project as part of the European Human Exposome Network (EHEN). Guest expert Dr. Tobias Stöger was then the first to present his work, on the mechanisms of particle-cell interactions during the course of particle-induced lung inflammation. As this involved some of the most recent findings from his lab, the presentation was not recorded, but keep a look out for upcoming publications to learn more. Bringing in the perspective of health related to climate change, Dr. Juan Aguilera discussed the role of climate change and air pollution in relation to immune changes and diseases in humans. To complete the theme of this symposium, normal versus pathological immune aging was presented by Prof. Niels Hellings, covering the key aspects of their triggers, measures, and intervention.

The symposium brought together more than 40 attendees, who participated in an insightful Q&A following each of the presentations. With a warm thank you to our guest experts, we’re looking forward to continue the exchange on the latest exposome research and to learn from leading experts in the field in the next EXIMIOUS Symposium. If you’d like to be notified about the next EXIMIOUS Symposium, subscribe here and we’ll send you an invitation in due time.

EHEN’s April 2022 Newsletter – insights into exposure data

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

EHEN’s April 2022 Newsletter – insights into exposure data

5 April 2022

The European Human Exposome Network (EHEN) just released its second newsletter and you don’t want to miss it. Alongside providing updates from the network’s working groups and the 9 exposome projects (including EXIMIOUS) that are part of it, the newsletter introduces the key types of datasets used to explore how diverse environmental exposures, such as air pollution, our lifestyles and our workplaces, affect our health.

According to recent studies, as many as 20% of all deaths in Europe are related to environmental factors and only 4.3% of the entire population has a clean bill of health. That is why EHEN is working on ways to change those numbers for the better, by studying a broad range of exposures and creating a toolbox for improved health care.

What types of datasets are key to this research? How are the data used? How does the result of innovation, such as Google AirView Car work? You can find the answer to these and many other questions by reading the full Newsletter.

Moreover, the newsletter presents the recently published profile papers of 8 of the 9 EHEN projects, including EXIMIOUS, in which the concepts of exposome studies, exposure data collection and analysis are described.

Enjoy the read!

The EXIMIOUS profile paper is published

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

The EXIMIOUS profile paper is published

16 February 2022

We’re happy to announce that the EXIMIOUS profile paper “The EXIMIOUS project—Mapping exposure-induced immune effects: connecting the exposome and the
immunome” has been published online in Environmental Epidemiology. It provides a comprehensive overview of the consortium’s aims, the type of data that will be collected, the overall approach and diverse methodologies used to identify immune fingerprints that reflect a person’s lifetime exposome or that are early predictors of disease.

Read the full paper to learn more about how our consortium brings together experts in immunology, toxicology, occupational health, clinical medicine, exposure science, epidemiology, bioinformatics, and sensor development that will study eleven European study populations covering the entire lifespan, including prenatal life.

Follow this space for udates on our latest progress and find our latest results and publications on the Outcomes page.

Immune-mediated disorders: take-aways from the 2nd EXIMIOUS Symposium​

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Immune-mediated disorders: take-aways from the 2nd EXIMIOUS Symposium

8 February 2022

More than 70 participants joined the second EXIMIOUS Symposium “Immune-mediated diseases: an interplay between environment and genetics” held online last Thursday, 3 February 2022. Did you miss it? Worry not, you can watch the full recording on the EXIMIOUS YouTube channel.

The four guest speakers, Prof. Ellen De Langhe (UZ Leuven, Belgium), Dr. Signe Hjuler Boudigaard Aarhus University Hospital, Denmark), Dr. Michael Pollard (The Scripps Research Institute, USA) and Dr. Tue Bjerg Bennike (Aalborg University, Denmark), each provided a different and unique lense through which to look at immune-mediated disorders, making the topic accessible for the non-expert audience while also sharing new insights for clinicians and epidemiologists.

The interplay between environment and genetics was explored through clinical case studies presented by Prof. De Langhe, the occupational perspective (i.e., how exposures experienced in the working environment might play a role in immuned-mediated disorders) discussed in terms of exposure to respirable crystalline silica by Dr. Boudigaard, the experimental animal models approach to studying autoimmune disorders associated to mercury exposure discussed by Dr. Pollard and the example of inflammatory bowel diseases (IBD), such as Crohn’s disease (CD) and ulecrative colitis (UC) presented by Dr. Bennike. The common thread was clear, and as also recalled by the speakers, it can be summarised by the famous quote of Judith Stern “Genetics load the gun, but the environment pulls the trigger”. 

While there is still much to be understood about this interplay of factors affecting our health, we take these symposia as opportunities to stimulate interest, raise awareness and hopefully also promote exchange of knowledge and further collaborations that can advance research towards a better understanding and, eventually, improved wellbeing.  

We’re looking forward to more exposome research highlights and insights during the Spring/Summer 2022 edition of the EXIMIOUS Symposium, so stay tuned. If you’d like to be notified about the next EXIMIOUS Symposium you can also subscribe here and we’ll send you an invitation in due time.

In the meanwhile, the next exposome-related event to look out for is the policy forum Researching the Roots of Obesity and the Impact across the Life-Course, planned for 30 March 2022 by the project LongITools, one of the projects that together with EXIMIOUS and other seven EU-funded projects is part of the Eurpean Human Exposome Network.

Register for the 2nd EXIMIOUS Symposium

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Register for the 2nd EXIMIOUS Symposium

24 January 2022

The second EXIMIOUS Symposium goes live on 3 February 2022! Register now and join us online at 16:00 – 18:00 (CET) to learn more about  “Immune-mediated diseases: an interplay between environment and genetics”.

This second EXIMIOUS Symposium is open to all audiences and will ease into the topic of immune-mediated diseases, providing an introduction to what these are, as well as how the working and living environments surrounding us play a role in their development. Our invited guest speakers will present their latest research on the topic and will be available to answer questions during a dedicated time for Q&A following each of the four presentations.

Programme EXIMIOUS Symposium “Immune-mediated diseases: an interplay between environment and genetics”:

Time Title Speaker
16:00 – 16:30
Auto-immune disorders – What does this mean & clinical relevance

 

Prof. Ellen De Langhe
UZ Leuven, Belgium

16:30 – 17:00
Occupational exposure to respirable crystalline silica and risk of autoimmune rheumatic diseases

 

Dr. Signe Hjuler Boudigaard
Aarhus University Hospital, Denmark

17:00 – 17:30
Environmental exposures, genetics and autoimmunity

 

Dr. K. Michael Pollard
The Scripps Research Institute, USA

17:30 – 18:00
Autoimmune diseases and breach of immune tolerance

 

Dr. Tue Bjerg Bennike
Aalborg University, Denmark

Join us online on 3 February 2022 at 16:00 (CET) for what we hope will be an informative and interactive exchange to learn more about how the environment affects our health.

Follow us on Twitter, Facebook and Linkedin to learn more about the project’s latest results and activities.

Partner in the spotlight: VHIR

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Partner in the spotlight: VHIR

January 10, 2022

We’re glad to welcome the New Year by continuing our partner in the spotlight series. Under the spotlight today is the Vall d’Hebrón Research Institute (VHIR), that promotes and develops biomedical research, innovation and teaching at Vall d’Hebron University Hospital, the largest hospital of Barcelona (Spain). 

Since its creation in 1994, VHIR works to find solutions to the health problems of society, and contribute to spread them around the world. Under the motto: ‘the research of today will become the medicine of tomorrow’, VHIR develops clinical research, collaborating in a complex sanitary environment, Campus Vall d’Hebrón. Close interaction with Vall d’Hebrón Hospital enables the development of pioneer translational research. The clinical and basic research activity of the Pneumology Group at VHIR is mainly focused on areas of inflammation and repair, respiratory failure and tissue hypoxia, and there is complementarity and interrelatedness of these areas for the study of diseases such as asthma, COPD, pulmonary fibrosis, infections, lung transplant, pulmonary hypertension and sleep-disordered breathing.

Within EXIMIOUS, the VHIR team including María-Jesus Cruz, Xavier Muñoz, David Espejo and David Soler investigate job exposures relative to immune function in an occupational cohort and in an occupational cohort:
1) the park workers cohort, icncluding workers from the Urban Pest Control and Surveillance Service in Spain, who experience a broad range of exposure to avian and fungal antigens. This cohort will be studied with specific emphasis to the degree of sensitization to specific antigens relative to the potential for risk of hypersentivity pneumonitis and autoimmune diseases development.
2) the Hypersentivity Pneumonitis (HP) cohort, which includes patients who suffer from this disease due to avian or fungal antigens. Hypersensitivity Pneumonitis is characterized by bronchoalveolar inflammation which originates from the inhalation of some usually organic substances. A population-based case control study will be established within EXIMIOUS with HP patients recruited from the pulmonary fibrosis clinic at VHIR. The patients will be matched with a healthy control group to compare and investigate whether exposure is different in patients versus controls.